These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19601820)
21. A review of basic principles of fractals and their application to pharmacokinetics. Marsh RE; Riauka TA; McQuarrie SA Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):278-88. PubMed ID: 18551095 [TBL] [Abstract][Full Text] [Related]
23. The evolving role of drug metabolism in drug discovery and development. Yengi LG; Leung L; Kao J Pharm Res; 2007 May; 24(5):842-58. PubMed ID: 17333392 [TBL] [Abstract][Full Text] [Related]
24. Novel Technologies Enable Mechanistic Understanding and Modeling of Drug Exposure and Response. Giacomini KM Clin Pharmacol Ther; 2020 May; 107(5):1045-1047. PubMed ID: 32304600 [No Abstract] [Full Text] [Related]
25. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery. Kiriyama A; Iga K; Shibata N Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911 [TBL] [Abstract][Full Text] [Related]
26. [Optimization of bioavailability of pharmacons]. Kata M; Aigner Z; Erös I Acta Pharm Hung; 1998 Mar; 68(2):107-11. PubMed ID: 9592935 [TBL] [Abstract][Full Text] [Related]
30. Crystal polymorphism in chemical process development. Lee AY; Erdemir D; Myerson AS Annu Rev Chem Biomol Eng; 2011; 2():259-80. PubMed ID: 22432619 [TBL] [Abstract][Full Text] [Related]
31. Basic overview of chemoinformatics. Engel T J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169 [TBL] [Abstract][Full Text] [Related]
32. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production. Kockmann N; Gottsponer M; Zimmermann B; Roberge DM Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163 [TBL] [Abstract][Full Text] [Related]
33. Theme issue "Solid state and solid dosage forms". Kleinebudde P Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869 [No Abstract] [Full Text] [Related]
34. "Innovative processes for bio-pharmaceuticals and poorly water-soluble API". Müller-Goymann C; Kwade A Eur J Pharm Biopharm; 2018 May; 126():1. PubMed ID: 29474867 [No Abstract] [Full Text] [Related]
35. The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space. Vallianatou T; Giaginis C; Tsantili-Kakoulidou A Adv Exp Med Biol; 2015; 822():187-94. PubMed ID: 25416989 [TBL] [Abstract][Full Text] [Related]
36. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines. Alavijeh MS; Palmer AM IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309 [TBL] [Abstract][Full Text] [Related]
37. A hierarchical screening methodology for physicochemical/ADME/Tox profiling. DeWitte RS; Robins RH Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):805-17. PubMed ID: 17014396 [TBL] [Abstract][Full Text] [Related]
38. Opening address 20th International Symposium on Pharmaceutical and Biomedical Analysis. Patel S J Pharm Biomed Anal; 2010 Jul; 52(3):330-1. PubMed ID: 19570643 [No Abstract] [Full Text] [Related]
39. Advancing technologies for accelerated drug development. Li AP Drug Discov Today; 2003 Mar; 8(5):200-2. PubMed ID: 12634011 [TBL] [Abstract][Full Text] [Related]
40. Applications of high-throughput ADME in drug discovery. Kassel DB Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]